Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

NCT00062036 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: interleukin-2 gene
BIOLOGICAL: therapeutic tumor infiltrating lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]